NCT05972031

Brief Summary

People of low socio economic status (SES) more often than others suffer from chronic diseases like diabetes mellitus, chronic obstructive pulmonary disease (COPD), or coronary diseases. Compared to others People of low SES more often have to deal with multiple diseases (multimorbidity) and experience worse health outcomes. The health literacy of people of low SES is often low. Current chronic disease management programs focus on reducing the burden of a single disease by prescribing medication, protocoled monitoring routines, or lifestyle advice. However, the effectiveness of these interventions is low in people with low SES, as the interventions insufficiently take into account the specific problems and needs of this (multimorbid) population. A person-centered and integrated-care approach, that puts the patient at the center of care instead of the disease and in which care is tailored to the individual patient with chronic disease(s), seems to be more appropriate, but only when low SES people are closely involved in the development, testing, and evaluation of such an approach. Also, certain preconditions should be met, such as training of specific knowledge and skills of the healthcare professionals involved. In the EMBOSS project, the investigators will develop, test, evaluate, and implement a person-centered integrated-care approach for and in close collaboration with people with low SES who have one or more chronic diseases. Thus, the EMBOSS study will have the potential to reducing health disparities in this group, to broadening the action perspectives of general practitioners and practice nurses for an increasing diverse patient population and to a better fit of lifestyle interventions in people of low SES.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
540

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 29, 2023

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

February 6, 2023

Completed
6 months until next milestone

First Posted

Study publicly available on registry

August 2, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

September 6, 2023

Status Verified

February 1, 2023

Enrollment Period

1.5 years

First QC Date

February 6, 2023

Last Update Submit

August 31, 2023

Conditions

Keywords

Primary carePerson-centeredIntegrated-careHealth literacyHealth disparitiesSocio-economic statusGeneral practice

Outcome Measures

Primary Outcomes (3)

  • patient-reported health-related quality of life Physical Health

    Global Physical Health \[Time Frame: Baseline, 6 months, 12 months\] Physical aspect of health-related quality of life as measured by the PROMIS-Global 10 instrument (T-scores; higher T-score indicates better physical aspect of HrQoL) Promis 10 is a patient-reported questionnaire in which the response options are presented as 5-point (as well as a single 11-point) rating scales.

    12 months

  • patient-reported health-related quality of life Mental health

    Global Mental Health \[Time Frame: Baseline, 6 months, 12 months\] Mental aspect of health-related quality of life as measured by the PROMIS-Global 10 instrument (T-scores; higher T-score indicates better mental aspect of HrQoL) Promis 10 is a patient-reported questionnaire in which the response options are presented as 5-point (as well as a single 11-point) rating scales.

    12 months

  • Patient-experienced quality of care

    atient-experienced quality of care \[Time Frame: Baseline, 6 months, 12 months\] Person-centredness of care as measured by the Person Centred Coordinated Care Experience Questionnaire (P3CEQ) instrument; minimum score 0, maximum score 30, higher score equals better P3CE.

    12 months

Secondary Outcomes (9)

  • Patient activation as measured by PAM

    Baseline, 6 months, 12 months

  • Health-related quality of life as measured by the EQ-5D-5L instrument

    Baseline, 6 months, 12 months

  • BMI

    Baseline, 6 months, 12 months

  • HbA1c

    Baseline, 6 months, 12 months

  • Blood glucose

    Baseline, 6 months, 12 months

  • +4 more secondary outcomes

Study Arms (2)

Person-centred integrated care intervention

EXPERIMENTAL

The core of the person-centered approach is a cyclical process and for EMBOSS developed for patients with low SES. The practice nurse in the GP will act as case manager and can consult other health providers. The first step in the intervention is assessing the integral health status of the patient (health across multiple domains), using a visual conversation tool. The second step is discussing the results with the patient. Personal goals are formulated in the third step. In the fourth step, the healthcare professional and patient will choose through shared-decision making the most appropriate interventions and support to achieve these goals, which are documented in a personal plan. Next, referrals are made if necessary and the treatment is started. An evaluation is planned and carried out. All practices in the EMBOSS intervention group will be trained by Pharos on how to recognize and provide GDM to low SES patients using appropriate communication skills and the specific tools.

Behavioral: Person-centred integrated care intervention

Usual care

NO INTERVENTION

Practices in the control group provide care as usual, which consists of the SDM programmes according to the national care standards and General Practice guidelines (NHG) for DM2, COPD and CVD. According to these protocolised programmes, patients with COPD, CVD or DM2 visit their general practice at a standard frequency per year (1 - 4 times) and standard monitoring measurements and topics are discussed. The practices that are randomised to the control group will not receive any additional training related to this study.

Interventions

See arm description.

Also known as: Usual care
Person-centred integrated care intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Currently enrolled in any of the single disease management programmes (usual care) for DM2, COPD, asthma or CVD

You may not qualify if:

  • Limited life expectancy (less than 3 months)
  • Patients with high level of SES (or educational level \> MBO2)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

RadboudUMC

Nijmegen, Netherlands

RECRUITING

MeSH Terms

Conditions

Chronic DiseaseMultiple Chronic Conditions

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Hester Van Bommel, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Cluster randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2023

First Posted

August 2, 2023

Study Start

January 29, 2023

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

September 6, 2023

Record last verified: 2023-02

Locations